510(k) K925355

BIOSIGN(TM_ RUBELLA - RUBELLA ANTIBODY TEST by Princeton Biomedix — Product Code LFX

K925355 is an FDA 510(k) premarket notification submitted by Princeton Biomedix for the device "BIOSIGN(TM_ RUBELLA - RUBELLA ANTIBODY TEST". The FDA issued a decision of Substantially Equivalent on Jul 12, 1994. The device falls under product code LFX (Enzyme Linked Immunoabsorbent Assay, Rubella), a Class II device regulated under 21 CFR 866.3510. Princeton Biomedix has 13 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jul 12, 1994
Date Received
Oct 22, 1992
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Enzyme Linked Immunoabsorbent Assay, Rubella
Device Class
Class II
Regulation Number
866.3510
Review Panel
MI
Submission Type
510(k)

Need the full FDA record for Princeton Biomedix? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K925355. Report a data issue: hello@regdatalab.com.